NTSK Stock Analysis: Netskope, Common Stock | NASDAQ
Software - Infrastructure | NASDAQ, USA | Market Cap: 7.763m USD | 12M Return: 1.9% | US64119N6085 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 114M
Rev. Trend: 100.0%
Warnings
Tailwinds
Seasonality 1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Netskope, Inc. (NASDAQ: NTSK) is a U.S.-based cybersecurity company headquartered in Santa Clara, California, that sells security, networking, and analytics solutions to large and mid-sized enterprises globally. The company was incorporated in 2012 (formerly Skope, Inc.) and completed its IPO in September 2025, placing it in the mid-cap range within the Information Technology sector.
The core of the business is the Netskope One platform, a cloud-native system that unifies security products (cloud access security broker, secure web gateway, data loss prevention, zero trust network access, and SaaS security posture management), networking products (Firewall-as-a-Service, SD-WAN, and dedicated egress IP), and analytics (user/entity behavior analytics and digital experience management) into a single offering.
Netskope operates within the cloud security and Secure Access Service Edge (SASE) market, an industry segment that has grown as enterprises shift workloads to cloud applications and adopt zero trust security models to protect distributed users, devices, and data. Its subscription-based platform model targets enterprise customers seeking to consolidate multiple point security and networking tools into a single cloud-delivered service.
- Enterprise customer growth accelerates Netskope One platform revenue
- Zscaler and Palo Alto compete fiercely in SASE market
- AI security products open new revenue stream for Netskope
| Net Income: -737.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.05 > 0.02 and ΔFCF/TA 25.81 > 1.0 |
| NWC/Revenue: 86.83% < 20% (prev -7.38%; Δ 94.21% < -1%) |
| CFO/TA -0.02 > 3% & CFO -41.1m > Net Income -737.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (405.0m) vs 12m ago 6.01% < -2% |
| Gross Margin: 69.92% > 18% (prev 68.86%; Δ 1.06% > 0.5%) |
| Asset Turnover: 63.21% > 50% (prev 74.39%; Δ -11.18% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.41 (Total Current Assets 1.39b - Total Current Liabilities 689.4m) / Total Assets 1.71b |
| B: -1.67 (Retained Earnings -2.86b / Total Assets 1.71b) |
| C: -0.60 (EBIT TTM -759.8m / Avg Total Assets 1.27b) |
| D: 0.10 (Book Value of Equity 156.8m / Total Liabilities 1.56b) |
| Altman-Z'' = -6.68 = D |
| DSRI: 0.98 (Receivables 188.0m/147.3m, Revenue 802.6m/615.5m) |
| GMI: 0.98 (GM 68.86% / 69.92%) |
| AQI: 0.50 (AQ_t 0.11 / AQ_t-1 0.23) |
| SGI: 1.30 (Revenue 802.6m / 615.5m) |
| TATA: -0.41 (NI -737.2m - CFO -41.1m) / TA 1.71b) |
| Beneish M = -3.18 (Cap -4..+1) = AA |
As of October 23, 2026, the stock is trading at USD 22.20 with a total of 7,891,005 shares traded. Over the past week, the price has changed by +8.56%, over one month by +19.68%, over three months by +85.70% and over the past year by +1.88%.
Current recommended Stop Loss: 20.40 (which is 8.1% or 1.5 ATR below the current price).
Netskope, Common Stock has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy NTSK.
- StrongBuy: 11
- Buy: 5
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 19.4 | -12.8% |
P/S = 9.6721
P/B = 48.3417
Revenue TTM = 802.6m USD
EBIT TTM = -759.8m USD
EBITDA TTM = -718.7m USD
Long Term Debt = 698.1m USD (from longTermDebt, last quarter)
Short Term Debt = 10.2m USD (from shortTermDebt, last quarter)
Debt = 766.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 34.1m
Net Debt = -122.7m USD (calculated: Debt 766.3m - CCE 889.0m)
Enterprise Value = 7.64b USD (7.76b + Debt 766.3m - CCE 889.0m)
Interest Coverage Ratio = unknown (Ebit TTM -759.8m / Interest Expense TTM 0.0)
EV/FCF = -86.41x (Enterprise Value 7.64b / FCF TTM -88.4m)
FCF Yield = -1.16% (FCF TTM -88.4m / Enterprise Value 7.64b)
FCF Margin = -11.02% (FCF TTM -88.4m / Revenue TTM 802.6m)
Net Margin = -91.84% (Net Income TTM -737.2m / Revenue TTM 802.6m)
Gross Margin = 69.92% ((Revenue TTM 802.6m - Cost of Revenue TTM 241.5m) / Revenue TTM)
Gross Margin QoQ = 73.92% (prev 73.54%)
Tobins Q-Ratio = 4.46 (Enterprise Value 7.64b / Total Assets 1.71b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 766.3m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -600.2m (EBIT -759.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.94 (Total Current Assets 1.39b / Total Current Liabilities 715.3m)
Debt / Equity = 4.89 (Debt 766.3m / totalStockholderEquity, last quarter 156.8m)
Debt / EBITDA = 0.17 (negative EBITDA) (Net Debt -122.7m / EBITDA -718.7m)
Debt / FCF = 1.39 (negative FCF - burning cash) (Net Debt -122.7m / FCF TTM -88.4m)
Total Stockholder Equity = 169.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -58.05% (Net Income -737.2m / Total Assets 1.71b)
RoE = -435.0% (Net Income TTM -737.2m / Total Stockholder Equity 169.5m)
RoCE = -87.58% (EBIT -759.8m / Capital Employed (Equity 169.5m + L.T.Debt 698.1m))
RoIC = -60.45% (negative operating profit) (NOPAT -600.2m / Invested Capital 993.0m)
WACC = 15.12% (E(7.76b)/V(8.53b) * Re(16.61%) + D(766.3m)/V(8.53b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 16.61% (= CAPM, Blume Beta Adj.) -> capped to 12.54%
Shares (quarterly) Correlation: 87.13 | Cagr: 9.84%
[DCF] Fair Price = unknown (Cash Flow -88.4m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 100.00 | Revenue CAGR: 32.00% | SUE: N/A | # QB: 0
EPS current Quarter (2026-10-31): EPS=-0.04 | Chg30d=N/A | Revisions=+22% | Analysts=17
EPS current Year (2027-01-31): EPS=-0.15 | Chg30d=+16.81% | Revisions=+85% | GrowthEPS=+69.0% | GrowthRev=+25.6%
EPS next Year (2028-01-31): EPS=-0.83 | Chg30d=+6.85% | Revisions=+57% | GrowthEPS=+22.6% | GrowthRev=+21.1%
[Analyst] Revisions Ratio: +77% (up=25, down=2)